The past week ushered in discoveries of a gene therapy treatment for glaucoma and a new way to inhibit colon cancer stem cells.
UCLA scientists are working on developing flu vaccines based on how the virus interacts with key proteins generated by the immune system.
Understanding how some helper T cells become killer T cells could lead to better vaccine design for HIV and hep C.
European researchers discovered how drugs bind to the enzyme DHODH, which could lead to more selective cancer drugs.
Two separate studies are unlocking the structure and function of Klotho proteins and shedding new light on their role in age-related disorders.
The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.
Researchers discovered a new mechanism that regulates the protein titin, which plays a key role in helping muscles function—especially in the heart.
NIH scientists have modeled the 3D structure of DHHC enzymes, which modify EGFRs, which are implicated in a range of cancers.
Scientists at Rice University say they have created a toolkit of gene “promoters” that can turn genes on and off at command.
A team at Duke University has created the first functioning human muscle from skin cell-derived induced pluripotent stem cells.